Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know
Werte in diesem Artikel
In the latest trading session, Albemarle (ALB) closed at $81.84, marking a +1.12% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.49%. Meanwhile, the Dow gained 0.38%, and the Nasdaq, a tech-heavy index, added 0.72%. Shares of the specialty chemicals company witnessed a gain of 2.52% over the previous month, trailing the performance of the Basic Materials sector with its gain of 5.24%, and the S&P 500's gain of 2.99%.Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of -$0.97, marking a 37.42% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $1.27 billion, down 5.92% from the prior-year quarter. ALB's full-year Zacks Consensus Estimates are calling for earnings of -$1.85 per share and revenue of $4.98 billion. These results would represent year-over-year changes of +20.94% and -7.48%, respectively. Investors might also notice recent changes to analyst estimates for Albemarle. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.47% higher within the past month. Currently, Albemarle is carrying a Zacks Rank of #3 (Hold). The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 231, positioning it in the bottom 7% of all 250+ industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions. Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Albemarle Corporation (ALB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Albemarle und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Albemarle
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Albemarle
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Albemarle Corp.
Analysen zu Albemarle Corp.
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
09.11.2017 | Albemarle Neutral | UBS AG | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
10.11.2017 | Albemarle Outperform | RBC Capital Markets | |
27.10.2017 | Albemarle Outperform | BMO Capital Markets | |
08.05.2017 | Albemarle Outperform | RBC Capital Markets | |
17.03.2017 | Albemarle Outperform | RBC Capital Markets | |
01.03.2017 | Albemarle Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2017 | Albemarle Hold | Deutsche Bank AG | |
09.11.2017 | Albemarle Neutral | UBS AG | |
25.09.2017 | Albemarle Neutral | Robert W. Baird & Co. Incorporated | |
10.03.2016 | Albemarle Neutral | Seaport Global Securities | |
03.02.2015 | Albemarle Market Perform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
16.08.2011 | Albemarle underperform | Oppenheimer & Co. Inc. | |
04.01.2006 | Update Albemarle Corp.: Underweight | JP Morgan |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Albemarle Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen